Mast Cells: A Link Between Migraine, POTS & EDS?
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- How might mast cells contribute to migraine disease?
- Which symptoms should prompt consideration of mast cell activation syndrome (MCAS) in a person with migraine? How are these MCAS symptoms distinguished from migraine symptoms?
- Which blood and urine biomarkers are used in MCAS evaluation, and how should they be timed relative to a mast cell activation episode?
- What is meant by the “autonomic trifecta” of MCAS, postural orthostatic tachycardia syndrome (POTS), and Ehlers-Danlos syndrome? How do these conditions interact with migraine?
- What are the main treatment options for MCAS, and how might they impact migraine?
- Why are people with MCAS, POTS, and Ehlers-Danlos often medication sensitive? How should migraine medications be started and dosed in this group?
- Which types of specialists or clinics are best positioned to evaluate and co-manage these overlapping conditions?
- What are the key gaps in epidemiology and clinical research on MCAS, POTS, Ehlers-Danlos, and migraine? How might registries or future studies change diagnosis and management in the coming years?
Interview Notes
- Dr. Jennifer Robblee, MD, MSc
- Article: “Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal Of The ECNM-AIM Consortium”
- Article: “Mast Cell Activation Syndrome: Current Understanding and Research Needs 2024 American Academy of Allergy, Asthma & Immunology”
- Article: “The 2017 International Classification of the Ehlers-Danlos Syndromes”
- Study: “The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome”
- The Ehlers-Danlos Society: Assessing Joint Hypermobility: The Beighton Scoring System
Treatments Mentioned
- Antileukotrienes (e.g., montelukast)
- Aspirin/acetylsalicylic acid (ASA)
- Cyproheptadine
- Cromolyn
- Epinephrine (EpiPen)
- H1 histamine receptor antagonists (e.g., Benadryl, Zyrtec)
- H2 histamine receptor antagonists (e.g., Pepcid)
- Ketotifen
- Low-histamine diet
- Omalizumab (Xolair)
- Prostaglandin blockers (e.g., NSAIDs)
Find 300+ treatments in our full Treatment Directory — available with a VIP Access Pass.
For additional links and resources, click here.
Disclaimer: The Migraine World Summit aims to bring you a variety of perspectives and expertise, free from bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan. Captions are auto-generated and may contain errors.
Jennifer Robblee, MD, MSc
Associate Professor of Neurology
Barrow Neurological Institute
Dr. Jennifer Robblee is a board-certified neurologist specializing in headache medicine at the Barrow Neurological Institute in Phoenix, Ariz. She balances her time between clinical work and research, focusing on refractory migraine and status migrainosus.
Dr. Robblee completed her medical training and neurology residency at the University of Toronto, where she also earned a Master of Science in quality improvement and patient safety. She further honed her expertise with a headache fellowship at the Mayo Clinic in Scottsdale. Her dedication to advancing headache medicine through innovative research and compassionate patient care has made her a respected figure in the field.
Go Beyond the Free Summit Interviews
- Full-length expert interviews beyond the 30-minute edits
- Revisit any 2026 session anytime
- Transcripts and audio downloads included
- Review insights before medical appointments
Related Talks for: Day 5 (2026)
Living With Migraine Through Times of Grief & Loss
Dawn C. Buse, PhD
Our Evolving Understanding of What Causes Migraine
Vince Martin, MD, AQH
Understanding Migraine Drug Side Effects
Teshamae Monteith, MD, FAHS, FAAN
The Migraine Trust is dedicated to helping people affected by migraine. We are the only UK migraine charity providing information and support, campaigning for awareness and change, and funding and promoting research.
Migraine Buddy is the #1 headache and migraine tracking application. Recommended by the best neurologists in the world, we empower our users to learn and communicate about their condition. Our community of 2.8 million contribute to migraine awareness and research.
Each day’s interviews are edited to fit the free Summit schedule. With the Pass, you can watch the full conversations, hear deeper insights from experts, and revisit the sessions anytime. Upgrade to unlock extended interviews, bonus content, and practical tools you can return to whenever you need them.
